Efficacy and safety of empagliflozin for type 2 diabetes: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Efficacy and safety of empagliflozin for type 2 diabetes: a systematic review and meta-analysis

Author:

Liakos A.¹,Karagiannis T.¹,Athanasiadou E.¹,Sarigianni M.¹,Mainou M.¹,Papatheodorou K.¹²,Bekiari E.¹,Tsapas A.¹³

Affiliation:

1. Clinical Research and Evidence-Based Medicine Unit, Second Medical Department; Aristotle University Thessaloniki; Thessaloniki Greece

2. Second Medical Department; Democritus University of Thrace; Alexandroupoli Greece

3. Harris Manchester College; University of Oxford; Oxford UK

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

Reference44 articles.

3. European Medicines Agency 2012 http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002322/WC500136024.pdf

4. U.S. Food and Drug Administration 2013 http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm345848.htm

5. European Medicines Agency 2013 http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002649/WC500156457.pdf

Cited by 170 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Treatment Approaches and Challenges;Nanoscience Applications in Diabetes Treatment;2023-12-17